tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Income Statement

Compare
7 Followers

Basilea Pharmaceutica Income Statement

Last quarter (Q4 2025), Basilea Pharmaceutica's total revenue was CHF128.44M, an increase of 76.60% from the same quarter last year. In Q4, Basilea Pharmaceutica's net income was CHF24.40M. See Basilea Pharmaceutica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
CHF 232.40MCHF 208.54MCHF 157.63MCHF 147.76MCHF 148.12M
Gross Profit
CHF 193.10MCHF 169.86MCHF 130.84MCHF 120.96MCHF 124.05M
Operating Expenses
CHF 141.50MCHF 108.69MCHF 111.64MCHF 104.62MCHF 122.88M
Depreciation and Amortization
CHF 0.00CHF 1.43MCHF 1.58MCHF 3.10MCHF 2.45M
EBITDA
CHF 51.60MCHF 63.13MCHF 23.18MCHF 26.21MCHF 6.72M
Operating Income
CHF 51.60MCHF 61.18MCHF 19.20MCHF 18.54MCHF 1.19M
Other Income/Expenses
CHF -5.70MCHF -917.00KCHF -8.74MCHF -6.44MCHF -7.98M
Pretax Income
CHF 45.90MCHF 60.26MCHF 10.46MCHF 12.10MCHF -6.79M
Net Income
CHF 40.20MCHF 77.59MCHF 10.45MCHF 12.15MCHF -6.83M
Per Share Metrics
Basic EPS
CHF 3.29CHF 6.42CHF 0.87CHF 1.02CHF -0.58
Diluted EPS
CHF 3.14CHF 5.83CHF 0.86CHF 1.02CHF -0.58
Weighted Average Shares Outstanding
12.22M 12.09M 11.99M 11.86M 11.68M
Weighted Average Shares Outstanding (Diluted)
12.80M 13.86M 12.14M 11.94M 11.68M
Currency in CHF

Basilea Pharmaceutica Earnings and Revenue History